Почетна › Рак простате › Minesota › Minneapolis
Kliničke studije za Рак простате u gradu Minneapolis, MN
22 studija za Рак простате traži učesnike na lokacijama u gradu Minneapolis i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Тражи се учесникФаза 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- и још 1
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Тражи се учесникФаза 2
- Hennepin County Medical Center, Minneapolis
The Vanguard Study: Testing a New Way to Screen for Cancer
Тражи се учесникЗдраве особе су добродошле
- Minneapolis VA Medical Center, Minneapolis
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 ми удаљено
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Тражи се учесникФаза 1
- University Of Minnesota, Minneapolis
Evaluating Prostate Cancer Patient Natural Killer Cell Function Across Racial Background and Addressing Functional Disparities With Trispecific Killer Engagers
Тражи се учесникОпсервациона студија
- University of Minnesota/Masonic Cancer Center, Minneapolis
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Тражи се учесникФаза 3
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0032), Saint Louis Park · 5 ми удаљено
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Тражи се учесникФаза 1
- University of Minnesota Medical Center, Minneapolis
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 2
- Health Partners Frauenshuh Cancer Center, Saint Louis Park · 5 ми удаљено
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Тражи се учесникФаза 3
- Abbott-Northwestern Hospital, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 ми удаљено
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Тражи се учесникФаза 3
- HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0072), Saint Louis Park · 5 ми удаљено
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Тражи се учесникФаза 3
- Minnesota Oncology Hematology PA, Minneapolis
- University of Minnesota Medical Center Fairview, Minneapolis
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Тражи се учесникФаза 1/2
- Research Site, Minneapolis
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Тражи се учесникФаза 3
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 ми удаљено
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Тражи се учесникФаза 1/2
- M Health Fairview University of Minnesota Medical Center, Minneapolis
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Тражи се учесникФаза 1
- M Health Fairview Clinics and Surgery Center, Minneapolis
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Тражи се учесникФаза 2
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
Тражи се учесникФаза 2
- Masonic Cancer Center, Minneapolis
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Тражи се учесникФаза 1
- Minnesota Oncology Hematology, Minneapolis
Axelopran for Advanced Cancer in Patients Receiving Opioids
Тражи се учесникФаза 2
- HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park · 5 ми удаљено
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Тражи се учесникФаза 3
- Abbott-Northwestern Hospital, Minneapolis
- Hennepin County Medical Center, Minneapolis
- Health Partners Inc, Minneapolis
- и још 1
Vitamin D for Prostate Endocrine Therapy
Тражи се учесникФаза 3
- Park Nicollet Clinic - Saint Louis Park, Saint Louis Park · 5 ми удаљено
Studije za Рак простате u drugim gradovima
- New York City, NY101 студија
- Houston, TX73 студија
- Los Angeles, CA64 студија
- Boston, MA56 студија
- Seattle, WA45 студија
- St. Louis, MO45 студија
- Chicago, IL45 студија
- Baltimore, MD45 студија
- San Francisco, CA44 студија
- Philadelphia, PA41 студија
- Nashville, TN40 студија
- Washington, DC39 студија
Ostale studije u gradu Minneapolis
- Немалоклетни карцином плућа29 студија
- Рак дојке23 студија
- Рак јајника23 студија
- Затајење срца22 студија
- Рак (све врсте)21 студија
- Карцином ендометријума20 студија
- Колоректални карцином20 студија
- Рак плућа20 студија
- Akutna mijeloidna leukemija19 студија
- Паркинсонова болест17 студија
- Коронарна болест срца15 студија
- Кардиоваскуларне болести15 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.